Background {#Sec1}
==========

Advances in medical knowledge and technology have led to improvements in survival rates following critical illness in the past decade \[[@CR1], [@CR2]\]. Intensive care unit (ICU) discharge no longer marks the endpoint of critical illness \[[@CR3]\]; rather the new challenge for the 21st century is the issue of survivorship \[[@CR4]\]. The burden of survivorship has been examined in longitudinal studies where it is evident that patients suffer ongoing muscle weakness, impaired physical functioning as well as neurocognitive and psychiatric symptoms collectively known as "post-intensive care syndrome" \[[@CR1], [@CR5]--[@CR7]\].

Increasing numbers of patients are admitted to critical care, with this rise projected to continue as new treatments emerge, expectations for care change, and population demographics and patterns of disease alter. In ICU, patients traditionally were heavily sedated and the focus was on maintaining maximum physiological stability of the organ systems with prolonged bed rest a necessary by-product \[[@CR8]\]. This is now being challenged as there is growing awareness that these management strategies may impact on long-term outcomes for survivors \[[@CR9]\]. Developing a greater understanding of aetiology, mechanisms, potential treatment and preventative strategies is important for minimization of morbidity associated with survival for patients and their families including the potential economic burden on the health-care system.

Impact of bed rest on the body systems from "bed rest" models {#Sec2}
-------------------------------------------------------------

Bed rest was first introduced as a medical treatment in the 19th century to minimize the metabolic demand on the body and enable a focus on healing and rest to promote recovery \[[@CR10]\]. However, lack of physical activity and prolonged bed rest have significant consequences on musculoskeletal, cardiovascular, respiratory, integumentary and cognitive systems and may be associated with harm \[[@CR11]\]. Bed rest models are commonly used to simulate the effects of space flight and physical inactivity \[[@CR12], [@CR13]\]. Anti-gravity muscles such as leg extensors and trunk musculature are preferentially affected by the loss of mechanical loading compared to hand and upper limb musculature \[[@CR12], [@CR14]\]. Three bed rest models are commonly used for muscle wasting research.

Limb suspension {#Sec3}
---------------

Commonly achieved in humans using a sling and crutches (occasionally with bespoke shoes), a limb suspension model was used by de Boer et al. \[[@CR15]\]. In a 23-day program, muscle mass was seen to reduce by 5.2 % within the first 2 weeks and subjects lost in total 10 % of quadriceps muscle mass by 23-days. Of note, this was not paralleled by continued up regulation of the intracellular signalling molecules driving muscle protein breakdown (MPB). Muscle activity across the knee joint of the suspended limb is not suppressed, suggesting that this is not the most effective model of lower limb immobilization \[[@CR16]\].

Limb casting {#Sec4}
------------

Limb casting, preventing knee joint movement, can induce further immobilization. Subjects are usually allowed to continue ambulation on crutches. Whilst numbers of subjects have been relatively small, decreases in muscle mass have been noted in several studies between 10 and 14 days \[[@CR17], [@CR18]\]. Gibson demonstrated decreased muscle protein synthesis (MPS) using a limb casting method, albeit over a longer period of 6 weeks \[[@CR19], [@CR20]\].

Bed rest and microgravity {#Sec5}
-------------------------

The most commonly used model, bed rest has been shown to cause muscle wasting within 10 days in healthy older adults \[[@CR21]\]. However, when a head-down position is added (simulating microgravity), Ferrando et al. demonstrated loss of muscle mass within 7 days \[[@CR22]\]. This combination has been used repeatedly to simulate muscle unloading in space flight unlike limb casting and limb suspension; bed rest ± microgravity induces the multisystem effects of immobilization \[[@CR16], [@CR22]\]. With immobilization, in addition to an overall reduction in muscle mass, there is a reduction in muscle fibre size \[[@CR12], [@CR14]\] with accelerated reduction in the strength of fast-twitch (type II) fibres compared to slow-twitch (type I) fibres which rely on oxidative metabolic processes, resulting in lower fatigue resistance capacity \[[@CR12], [@CR23]\]. There is not only a loss of muscle force generation capacity due to reduction in muscle mass, contractile proteins, but also alterations in muscle electromyographic activity. This highlights changes occur in terms of the neural or muscle membrane excitability to enable potentiation of a muscle contraction \[[@CR24], [@CR25]\]. Immobility also increases the production of pro-inflammatory cytokines and reactive oxygen species with subsequent muscle proteolysis promoting overall muscle loss \[[@CR26], [@CR27]\]. As a result of loss of muscle mass, up to 40 % of muscle strength can be lost within the first week of immobilization \[[@CR12]\]. Bed rest studies have demonstrated preferential atrophy of the anti-gravity muscle groups such as soleus, back extensors and quadriceps musculature \[[@CR12], [@CR14]\]. Fibre atrophy may relate to the initial fibre size, which may explain partly why anti-gravity musculature which consist primarily of Type I fibres preferentially atrophy. Loss of muscle contractile protein and fibre size is only one component to the loss of force generation capability, and other factors which interplay include neural, hormonal, and cellular signalling processes.

Skeletal tissue also responds rapidly to changes in mechanical loading during bed rest \[[@CR12]\]. There is greater bony resorption than formation, resulting in a net reduction in bone integrity and demineralization \[[@CR14]\] which preferentially affects trabecular bone \[[@CR12]\] and may therefore place an individual at higher risk of fractures and future morbidity and mortality. Changes in skeletal integrity occur at a slower rate compared to muscular changes, with one study reporting a 1 % reduction in bone density within the vertebral column after 1 week of immobility \[[@CR28]\]. A recent study demonstrated early and rapid bone demineralization in individuals with acute respiratory distress syndrome and a concomitant increase in fracture risk by \~20 % \[[@CR29]\]. This is the first study to demonstrate this within the critical care environment \[[@CR29]\].

Other organs systems are affected too by immobilization. A full discussion on these is beyond the scope of this review. Inactivity and prolonged bed rest have also been shown to result in cardiac deconditioning affecting both the central and peripheral cardiovascular systems. Stroke volume has been shown to be reduced by 30 % within the first month of bed rest, with an associated increase in resting heart rate, and signs of orthostatic intolerance can develop within 72 h of inactivity \[[@CR30]--[@CR33]\]. These changes are mediated to a large extent by a reduction in blood volume \[[@CR34]\]. The respiratory system is also negatively affected with development of atelectasis and increased likelihood of developing respiratory complications such as pneumonia \[[@CR32]\]. Other secondary consequences include increased risk of thromboembolic events, pressure ulcers, insulin resistance, and development of delirium or cognitive processing impairments and alterations in sleep patterns \[[@CR26], [@CR32], [@CR35]\]. While the majority of immobility related pathophysiology normalizes upon mobilization and reduction in sedation, the effects on skeletal muscle do not. Instead muscle wasting results in muscle weakness, which in critical illness is termed Intensive Care Unit-Acquired weakness (ICU-AW).

Intensive care unit-acquired weakness---incidence and diagnosis {#Sec6}
---------------------------------------------------------------

Intensive care unit-acquired weakness is defined as clinically detectable weakness in which there is no plausible aetiology other than critical illness \[[@CR36]\] and is characterized by bilateral symmetrical flaccid paresis of the limbs \[[@CR37]\]. It is associated with prolonged hospitalization, delayed weaning and increased mortality \[[@CR38]--[@CR40]\]. The reported incidence of ICU-AW varies depending on the patient population, timing of assessment and diagnostic methods used (i.e. electrophysiological, histological or clinical) \[[@CR41]--[@CR44]\]. In one prospective study, ICU-AW was clinically diagnosed in 25 % of patients receiving mechanical ventilation for greater than 7 days \[[@CR41]\], and in another study using electrophysiological testing, the incidence was 58 % \[[@CR45]\]. The incidence of ICU-AW is significantly higher in individuals with sepsis and has been reported to be as high as 50--100 % \[[@CR46]--[@CR49]\]. The diagnosis of ICU-AW is primarily clinical based on manual muscle strength testing using the Medical Research Council sum score to assess bilaterally six muscle groups in the upper and lower limb \[[@CR50]\]. A score of less than 48 out of 60 is considered indicative of ICU-AW \[[@CR51]\]. A two-tier approach to screening for the presence of ICU-AW has been recommended involving (1) evaluation of handgrip strength and (2) manual muscle strength testing using an isometric approach with the Medical Research Council sum score \[[@CR52]\]. Additional testing can be performed such as electromyography, nerve conduction or muscle biopsy to determine the presence of neuropathy, myopathy or neuromyopathy \[[@CR50]\]. However, these investigations are not routinely available in every clinical setting and are more time-consuming, invasive and costly to perform.

Non-immobilization aetiology and risk factors for the development of ICU-AW {#Sec7}
---------------------------------------------------------------------------

The aetiology by which critical illness leads to muscle weakness is complex and involves several inter-related processes \[[@CR53]\]. Investigation into the risk factors for the development of ICU-AW have been limited by poor study design (predominantly retrospective chart review within a single centre), small sample sizes, lack of standardized definitions and heterogeneity of the ICU cohorts, thus limiting the comparability between studies. A number of independent risk factors have been correlated with the development of ICU-AW including sepsis \[[@CR54]\]; the presence of organ failure involving two or more organs and severity of illness \[[@CR41], [@CR55]--[@CR58]\]; duration of mechanical ventilation \[[@CR41]\]; ICU length of stay \[[@CR44], [@CR54]\]; female gender \[[@CR41]\]; hyperglycaemia \[[@CR44], [@CR59]\] and immobility \[[@CR41], [@CR53], [@CR60]\]. Sepsis additionally has adverse effects on mitochondrial function, which may have a further compounding effect on muscle wasting \[[@CR61]\]. Pathophysiologically immobility and local and systemic inflammation are believed to act synergistically to promote significant muscle loss in the critically ill patient \[[@CR53]\]. Whilst the use of neuromuscular blockade agents has been previously cited as a risk factor, there remains no evidence for its association \[[@CR62]\]---the only randomized trial performed showed no increase in ICU-AW following 48 h of paralysis \[[@CR63]\], even in patients receiving concomitant steroids \[[@CR64]\]. However, the relative contribution of each of these factors has not yet been established, and a full discussion on non-immobilization-related risk factors is beyond the scope of this review.

Sedation---a risk factor that potentially augments the pathophysiology of immobilization {#Sec8}
----------------------------------------------------------------------------------------

Sedation remains an unknown factor in immobilization-related muscle remodelling. Propofol and benzodiazepines positively modulate the inhibitory function of the neurotransmitter gamma-aminobutyric acid (GABA) \[[@CR65], [@CR66]\]. GABA facilitates the opening of the voltage-gated chloride channels in skeletal muscle, decreasing muscle excitability \[[@CR66], [@CR67]\]. Barbiturates and ketamine attenuate the response of excitatory neurotransmitters such as glutamate, decreasing muscle tone by acting on motor associated neurones in the spinal cord via *N*-methyl-[d-]{.smallcaps}aspartate (NMDA) receptors \[[@CR66], [@CR68], [@CR69]\]. Recently, NMDA receptors have been discovered on the post-synaptic endplate in skeletal muscle \[[@CR70]\]. Skeletal muscle is believed to require active support from neuronal trophic factors such as neuregulin to maintain mass. Pharmacological attenuation of their transport by sedatives may compound muscle wasting \[[@CR71], [@CR72]\]. Thus, continued sedation is likely to have a greater effect on muscle atrophy and weakness than "conscious immobility" in the absence of sedation (Fig. [1](#Fig1){ref-type="fig"}). It is reasonable to postulate that the beneficial effects of minimizing sedation \[[@CR73]--[@CR76]\] might, at least in part, be due to a relative maintenance of muscle mass and function. This hypothesis has yet to be formally examined. There are intrinsic difficulties in separating the effects of sedatives from bed rest in humans and ethical issues in animal studies. It may be that cell culture work, using human myocytes, is required so as to advance understanding of this issue.Fig. 1The immobility period. Providing conceptualization of the rate of muscle wasting in different states of immobilization based on the research literature

The pathophysiological effect of immobilization on skeletal muscle in critical illness {#Sec9}
--------------------------------------------------------------------------------------

Skeletal muscle mass is regulated by a balance between MPS and MPB \[[@CR77]\]. In a 70 kg human, approximately 280 g of protein is synthesized and degraded each day \[[@CR78]\]. The two processes are linked, in a fashion described by Millward as facilitative or adaptive processes, whereby MPS facilitates (allows modulation of muscle mass) and MPB adapts (limiting said modulation) \[[@CR79]\]. When exposed to an anabolic stimulus, MPS rises. MPB rises too, but to a lesser amount, resulting in a net synthetic balance. In response to an anti-anabolic stimulus, MPS decreases and MPB decreases to a lesser degree, resulting in a net breakdown.

The interaction between critical illness and bed rest may result in greater muscle loss compared to bed rest alone \[[@CR26], [@CR53]\]. The musculoskeletal system is a highly plastic and adaptive system, responding quickly to changing demands \[[@CR43], [@CR80], [@CR81]\]. Relatively short periods of immobilization decrease MPS, with no effect on MPB \[[@CR15]\]. Furthermore, this altered balance is relatively resistant to high dose amino acid delivery \[[@CR82]\]. This is in contrast to studies in animals, in which MPB appears the dominant process \[[@CR83], [@CR84]\]. Immobilization has significant effects on peripheral muscle aerobic capacity \[[@CR21]\], contractility \[[@CR85]\], insulin resistance \[[@CR86]\] and architecture \[[@CR87]\]. Microvascular dysfunction occurring in severe sepsis is associated with immobilization and may have an additive effect on reducing MPS \[[@CR86], [@CR88]\]. In critically ill patients, MPS is reduced even with nutritional delivery, with increased MPB seen, leading to a net catabolic state and thus muscle wasting \[[@CR58]\].

Muscle wasting occurs early and rapidly in the critical care setting with up to 30 % of muscle mass lost within the first 10 days of an ICU admission \[[@CR58], [@CR89]\]. The rate of wasting for muscle thickness was fastest for the rectus femoris muscle (9 %) compared to vastus intermedius (1 %) and vastus lateralis (0.2 %) musculature (within the quadriceps complex) in the first 72 h after an ICU admission \[[@CR89]\]. The difference in the pattern of muscle wasting may be partly explained by the difference in functionality of the muscle and fibre type composition. Rectus femoris is a power muscle predominantly consisting of type II fibres (fast twitch) whereas vastus intermedius is a deep mono-articular stabilizer knee extensor predominantly consisting of type I fibres (slow twitch) \[[@CR89]\].

Muscle quality or echotexture deteriorates significantly in the first 10 days of an ICU admission with infiltration of non-contractile tissue such as connective tissue and oedema \[[@CR89], [@CR90]\]. Changes in the muscle quantity and quality using ultrasonography have been correlated with measures of muscle strength and function \[[@CR89]\]. Recent human studies have demonstrated a reduction in muscle myofibre size with preferential proteolysis of the thick myosin filaments \[[@CR91], [@CR92]\] with one trial demonstrating a dramatic increase in protein degradation of up to 160 % \[[@CR92]\]. The same phenomenon has been observed in bed rest studies \[[@CR93]\]. Finally, immobilization results in a loss of contractile function disproportionate to the loss of muscle mass \[[@CR25]\]. Using single-fibre isolation methods, this phenomenon has been observed in critically ill patients \[[@CR94]\].

Intracellular signalling in immobilization and critical illness {#Sec10}
---------------------------------------------------------------

The signalling pathways underlying altered protein homeostasis in immobilization has been extensively studied. Immobilization upregulates E3 ligases \[[@CR95]\] and other components of the ubiquitin proteasome pathway \[[@CR96], [@CR97]\]. In critically ill patients, the same pathways are unregulated and lead to altered protein homeostasis \[[@CR58]\]. Upstream activators of the ubiquitin proteasome pathway may exist in critical illness separate to immobilization up-regulated pathways, which may account for the differences in wasting seen between models and the clinical scenario. Local and systemic inflammatory processes in critically ill individuals may further disrupt the balance between muscle protein synthesis and protein breakdown, leading to a greater reduction in muscle mass \[[@CR27], [@CR98], [@CR99]\]. Increased circulating inflammatory cytokines (such as tumor necrosis factor-alpha (TNF-α) and interleukin-1 beta (IL1-β) may also drive mitochondrial oxidative stress and increase intracellular calcium \[[@CR98]\]. This is postulated to trigger muscle proteolytic pathways \[[@CR98], [@CR100]\] and interfere with insulin signalling, leading to anabolic resistance \[[@CR88]\], and contribute to electrophysiological inexcitability of the muscle \[[@CR101], [@CR102]\].

Intramuscular metabolic pathway alterations have also been examined in immobilization models. Insulin resistance was first described in 1959 following bed rest in healthy subjects \[[@CR103]\]. The development of insulin resistance subsequent to immobilization has been repeatedly observed \[[@CR86], [@CR104], [@CR105]\]. Insulin resistance occurs in critical illness and immobilization may contribute to this \[[@CR106]\]. The pathogenesis of insulin resistance seems similar---that of decrease in intramuscular glucose transporter 4 (GLUT-4) concentrations seen in immobilized muscle and in critically ill patients \[[@CR106], [@CR107]\]. Free reactive oxygen species and other radical species can cause upregulation of other protein degradation molecules such as calpains and caspases which can cause sarcolemma damage and interact directly with the myofilament contractile function by modifying protein structure and thus affecting contractile capacity \[[@CR94], [@CR98]\].

A recent paper by Files and colleagues proposed muscle dysfunction following critical illness could be categorized into early and late stages of muscle wasting \[[@CR108]\]. The early phase occurs within days of the onset of critical illness with marked muscle protein degradation and muscle atrophy secondary to upregulation of ubiquitin--proteasome, autophagy and calpain-caspase pathways \[[@CR108]\]. Late-phase muscle weakness refers to the ongoing impairment in muscle function due to ongoing disuse and failure to regain muscle homeostasis and pre-existing underlying neuromuscular deficits prior to ICU admission \[[@CR108]\]. Whilst this is an attractive model to aid decision making regarding timings of exercise interventions \[[@CR109]\], multiple barriers to early mobilization exist.

Barriers to early activity and mobilization {#Sec11}
-------------------------------------------

Although prolonged inactivity is recognized as harmful, current levels of activity and mobilization are low from point prevalence and observational data \[[@CR110]--[@CR112]\]. The main barriers identified include sedation, the presence of endotracheal tube and potential respiratory and/or haemodynamic instability \[[@CR110]--[@CR112]\]. One study reported 47 % of barriers identified were due to modifiable factors \[[@CR113]\]. A recent behavioural mapping study demonstrated patients in critical care are inactive outside of dedicated rehabilitation time, and individuals who were ventilated were 5 times more likely to be inactive \[[@CR114]\]. All individuals in this study spent at least one-third of their day alone and inactive irrespective of ventilation or sedation state \[[@CR114]\]. Low-physical activity levels and muscle strength are associated with reduced physical function at intensive care discharge \[[@CR115]\]. Although the evidence demonstrating early rehabilitation is safe and feasible \[[@CR116], [@CR117]\], and the development of clinical consensus guidelines for undertaking in-bed and out of bed active mobilization \[[@CR118]\], activity levels continue to remain low. A significant culture change is needed and staffing and environmental barriers need to be considered independently of patient-related barriers to promote early activity and mobilization.

Potential rehabilitation strategies to reverse effects of prolonged bed rest in the ICU setting {#Sec12}
-----------------------------------------------------------------------------------------------

To reverse the effects of immobilization on the musculoskeletal system, it is important to consider methods of training to enable "overload"---by placing greater demand on the muscle to potentially mitigate the severity of immobilization induced muscle wasting \[[@CR24]\]. Considerations of the specificity of training in terms of limb position, types of training (strength, endurance, interval) as well as methods to artificially mimic physiologically induced activity are important constructs currently being investigated.

Assistive technology {#Sec13}
--------------------

Muscle wasting occurs early and rapidly as described earlier in this review in individuals with critical illness \[[@CR58]\]. There is growing interest in the use of assistive technologies, in particular supine cycle ergometry and muscle stimulation to commence rehabilitation early in the ICU admission without the need for direct patient engagement \[[@CR119]\]. In a randomized controlled trial (RCT) of cycle ergometry, a significant difference was seen in the intervention cohort for 6-min walk distance and isometric quadriceps strength at hospital discharge \[[@CR120]\]. Although this study demonstrated promising results for enhancing recovery of muscle strength and functional outcomes, there was a significant delay in the time to commencement of the intervention---2 weeks post ICU admission \[[@CR120]\]. Artificial stimulation of the skeletal muscles through the use of low voltage electrical impulses delivered through the skin to the underlying muscle via surface electrodes \[[@CR121]\] is another assistive modality, which can be utilized without the need for volitional activation \[[@CR122]\]. The efficacy for electrical muscle stimulation is inconclusive \[[@CR122]\]. Finally, there is also growing interest in functional electrical stimulation assisted cycling---stimulation of multiple muscle groups in a functional manner facilitating cycling \[[@CR123]\]. Preliminary research has demonstrated the safety and feasibility of this form of intervention when commenced early in the ICU admission period in individuals with sepsis \[[@CR123]\], and a large multi-centre randomized controlled trial is currently in progress to determine the efficacy in terms of functional and cognitive recovery.

Active rehabilitation {#Sec14}
---------------------

Optimization of sedation and delirium practices is necessary to enable patient engagement with active rehabilitation. Clinical practice guidelines have been published on sedation and delirium practices with consideration of mobilization within the bundle of care \[[@CR124], [@CR125]\]. Schweickert and colleagues published a landmark Randomized Controlled Trial examining early physical and occupational therapy commencing within the first 48 h of ICU admission and demonstrated improved functional recovery at hospital discharge and reduced delirium duration \[[@CR72]\]. Denehy and colleagues examined the efficacy of exercise rehabilitation commencing during the ICU admission and continuing across the continuum of recovery into the outpatient setting compared to usual care practices \[[@CR46]\]. There was no significant difference found in terms of 6-min walk distance results at 12 months; however, exploratory analyses demonstrated the rate of change over time and mean between group differences were higher in the intervention cohort \[[@CR46]\], and pre critical illness disease status may have been an unaccounted for factor \[[@CR126]\]. The evidence for rehabilitation in the ICU appears to improve quality of life, physical function and muscle strength \[[@CR127]\]; however, the optimal timing, dosage and specific intervention type have not been elucidated.

Conclusions {#Sec15}
===========

Prolonged immobility is harmful with rapid reductions in muscle mass, bone mineral density and impairment in other body systems evident within the first week of bed rest, which is further exacerbated in individuals with critical illness. Therapeutic strategies to enable early rehabilitation and physical activity need to be developed alongside a culture of physical activity in the critical care setting. Addressing these concerns will enable a paradigm shift from bed rest and inactivity to physical activity and mobility in the future.
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